Dr. Ashutosh (Ash) K. Tewari

Dr. Ashutosh K. Tewari, MD, MBBS, MCh, FRCS (Hon.), is a globally recognized urologic surgeon and the System Chair of Urology at the Mount Sinai Health System, where he also serves as Surgeon-in-Chief at the Tisch Cancer Hospital. He earned his medical degree and multiple gold-medal awards from GSVM Medical College in Kanpur, India, before completing his urology training in India and additional fellowships in urologic oncology at UCSF, University of Florida, and Henry Ford Hospital. As Director of Robotic Prostatectomy and of the Prostate Cancer Program, he has performed over 10,000 robotic radical prostatectomy procedures. Dr. Tewari practices at Mount Sinai’s main campus in Manhattan and affiliated hospitals, offering both in-person and telehealth consultations for patients with prostate, bladder, and other urologic cancers.

He is celebrated for pioneering advanced robotic-assisted prostatectomy techniques designed to preserve urinary continence and sexual function. His “Hood” surgical method emphasizes anatomical precision and nerve-sparing, and he led the first robotic prostatectomy team in the U.S. in 2004. At the forefront of clinical research, he holds an NIH R01 grant and Department of Defense funding for studies involving real-time tissue imaging and immunotherapies in prostate cancer. He also heads the Tewari Lab, which investigates the genomic foundations of prostate cancer and works to translate these findings into advanced diagnostic imaging and personalized treatment strategies. His contributions earned him prestigious accolades such as the AUA Gold Cystoscope Award, the Golden Robot Award, and repeated listings in New York Magazine’s Top Doctors.

Dr. Tewari is a dedicated educator, mentor, and leader in urologic oncology. He is President of the Society for Urologic Robotic Surgeons and serves in leadership roles with professional societies such as the American Urological Association and the Society of Urologic Oncology. He founded the Center for Prostate Cancer at Mount Sinai and launched the mobile prostate cancer screening initiative in underserved New York communities. Through his extensive clinical experience, innovative surgical methods, groundbreaking research, and service to education and community health, Dr. Tewari is recognized as a top global expert in robotic prostate cancer surgery.